nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—Crohn's disease	0.929	1	CiPCiCtD
Nelarabine—Guillain-Barre syndrome—Mesalazine—Crohn's disease	0.00311	0.0678	CcSEcCtD
Nelarabine—DGUOK—smooth muscle tissue—Crohn's disease	0.00266	0.132	CbGeAlD
Nelarabine—DGUOK—mammalian vulva—Crohn's disease	0.00239	0.119	CbGeAlD
Nelarabine—DGUOK—lymphoid tissue—Crohn's disease	0.00213	0.106	CbGeAlD
Nelarabine—DGUOK—digestive system—Crohn's disease	0.0021	0.104	CbGeAlD
Nelarabine—Azacitidine—DNMT3A—Crohn's disease	0.00159	0.4	CrCbGaD
Nelarabine—Decitabine—DNMT3A—Crohn's disease	0.00155	0.39	CrCbGaD
Nelarabine—POLA1—mammalian vulva—Crohn's disease	0.00148	0.0733	CbGeAlD
Nelarabine—ADA—mammalian vulva—Crohn's disease	0.00137	0.068	CbGeAlD
Nelarabine—Polyp—Mercaptopurine—Crohn's disease	0.00137	0.0298	CcSEcCtD
Nelarabine—Cyst—Mercaptopurine—Crohn's disease	0.00124	0.0271	CcSEcCtD
Nelarabine—ADA—lymphoid tissue—Crohn's disease	0.00122	0.0604	CbGeAlD
Nelarabine—ADA—digestive system—Crohn's disease	0.0012	0.0596	CbGeAlD
Nelarabine—DGUOK—lymph node—Crohn's disease	0.0012	0.0595	CbGeAlD
Nelarabine—Sinus tachycardia—Mesalazine—Crohn's disease	0.00112	0.0244	CcSEcCtD
Nelarabine—DCK—mammalian vulva—Crohn's disease	0.000911	0.0452	CbGeAlD
Nelarabine—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.000896	0.0196	CcSEcCtD
Nelarabine—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.000847	0.0185	CcSEcCtD
Nelarabine—Adenosine triphosphate—HSPA1B—Crohn's disease	0.000836	0.21	CrCbGaD
Nelarabine—Polyp—Azathioprine—Crohn's disease	0.000814	0.0178	CcSEcCtD
Nelarabine—DCK—lymphoid tissue—Crohn's disease	0.000809	0.0401	CbGeAlD
Nelarabine—DCK—digestive system—Crohn's disease	0.000799	0.0396	CbGeAlD
Nelarabine—Neoplasm—Mercaptopurine—Crohn's disease	0.000752	0.0164	CcSEcCtD
Nelarabine—Transaminases increased—Mesalazine—Crohn's disease	0.000742	0.0162	CcSEcCtD
Nelarabine—Cyst—Azathioprine—Crohn's disease	0.000741	0.0162	CcSEcCtD
Nelarabine—POLA1—lymph node—Crohn's disease	0.00074	0.0367	CbGeAlD
Nelarabine—Sepsis—Mercaptopurine—Crohn's disease	0.000722	0.0157	CcSEcCtD
Nelarabine—Hypomagnesaemia—Mesalazine—Crohn's disease	0.00071	0.0155	CcSEcCtD
Nelarabine—ADA—lymph node—Crohn's disease	0.000686	0.0341	CbGeAlD
Nelarabine—Burning sensation—Mesalazine—Crohn's disease	0.00065	0.0142	CcSEcCtD
Nelarabine—Blood potassium decreased—Prednisone—Crohn's disease	0.000628	0.0137	CcSEcCtD
Nelarabine—Rigors—Azathioprine—Crohn's disease	0.000607	0.0132	CcSEcCtD
Nelarabine—Opportunistic infection—Prednisone—Crohn's disease	0.000593	0.0129	CcSEcCtD
Nelarabine—Pleural effusion—Mesalazine—Crohn's disease	0.000589	0.0129	CcSEcCtD
Nelarabine—Blood disorder—Mesalazine—Crohn's disease	0.00054	0.0118	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Prednisone—Crohn's disease	0.000514	0.508	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—Crohn's disease	0.000499	0.493	CbGdCrCtD
Nelarabine—Hypocalcaemia—Mesalazine—Crohn's disease	0.000493	0.0108	CcSEcCtD
Nelarabine—Blood bilirubin increased—Mesalazine—Crohn's disease	0.000477	0.0104	CcSEcCtD
Nelarabine—DCK—lymph node—Crohn's disease	0.000456	0.0226	CbGeAlD
Nelarabine—Stomatitis—Mercaptopurine—Crohn's disease	0.000453	0.00989	CcSEcCtD
Nelarabine—Neoplasm—Azathioprine—Crohn's disease	0.000448	0.00977	CcSEcCtD
Nelarabine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00044	0.0096	CcSEcCtD
Nelarabine—Neuropathy—Mesalazine—Crohn's disease	0.000424	0.00924	CcSEcCtD
Nelarabine—Coma—Mesalazine—Crohn's disease	0.000412	0.00899	CcSEcCtD
Nelarabine—Febrile neutropenia—Prednisone—Crohn's disease	0.000397	0.00866	CcSEcCtD
Nelarabine—Hypertonia—Mesalazine—Crohn's disease	0.000396	0.00863	CcSEcCtD
Nelarabine—Malnutrition—Mercaptopurine—Crohn's disease	0.000363	0.00793	CcSEcCtD
Nelarabine—Anaemia—Mercaptopurine—Crohn's disease	0.000336	0.00733	CcSEcCtD
Nelarabine—Lethargy—Mesalazine—Crohn's disease	0.000334	0.00729	CcSEcCtD
Nelarabine—Osteoarthritis—Mesalazine—Crohn's disease	0.000328	0.00715	CcSEcCtD
Nelarabine—Leukopenia—Mercaptopurine—Crohn's disease	0.000325	0.0071	CcSEcCtD
Nelarabine—Neuritis—Prednisone—Crohn's disease	0.00032	0.00698	CcSEcCtD
Nelarabine—Arthralgia—Mercaptopurine—Crohn's disease	0.000309	0.00675	CcSEcCtD
Nelarabine—Fungal infection—Prednisone—Crohn's disease	0.000309	0.00674	CcSEcCtD
Nelarabine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000307	0.00669	CcSEcCtD
Nelarabine—Oedema—Mercaptopurine—Crohn's disease	0.000297	0.00647	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000295	0.00643	CcSEcCtD
Nelarabine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00029	0.00634	CcSEcCtD
Nelarabine—Petechiae—Prednisone—Crohn's disease	0.00029	0.00633	CcSEcCtD
Nelarabine—Abdominal distension—Mesalazine—Crohn's disease	0.000285	0.00622	CcSEcCtD
Nelarabine—Anorexia—Mercaptopurine—Crohn's disease	0.000283	0.00617	CcSEcCtD
Nelarabine—Pneumonia—Azathioprine—Crohn's disease	0.000279	0.00608	CcSEcCtD
Nelarabine—Infestation NOS—Azathioprine—Crohn's disease	0.000277	0.00605	CcSEcCtD
Nelarabine—Infestation—Azathioprine—Crohn's disease	0.000277	0.00605	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00027	0.0059	CcSEcCtD
Nelarabine—Neutropenia—Mesalazine—Crohn's disease	0.000265	0.00578	CcSEcCtD
Nelarabine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000262	0.00572	CcSEcCtD
Nelarabine—Decreased appetite—Mercaptopurine—Crohn's disease	0.000258	0.00563	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000256	0.00559	CcSEcCtD
Nelarabine—Pneumonia—Mesalazine—Crohn's disease	0.000254	0.00554	CcSEcCtD
Nelarabine—Infestation NOS—Mesalazine—Crohn's disease	0.000252	0.00551	CcSEcCtD
Nelarabine—Infestation—Mesalazine—Crohn's disease	0.000252	0.00551	CcSEcCtD
Nelarabine—Depression—Mesalazine—Crohn's disease	0.000252	0.00549	CcSEcCtD
Nelarabine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000247	0.0054	CcSEcCtD
Nelarabine—Stomatitis—Mesalazine—Crohn's disease	0.000246	0.00537	CcSEcCtD
Nelarabine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000239	0.00521	CcSEcCtD
Nelarabine—Epistaxis—Mesalazine—Crohn's disease	0.000238	0.00519	CcSEcCtD
Nelarabine—Sinusitis—Mesalazine—Crohn's disease	0.000237	0.00517	CcSEcCtD
Nelarabine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000235	0.00512	CcSEcCtD
Nelarabine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000224	0.00489	CcSEcCtD
Nelarabine—Neuropathy—Prednisone—Crohn's disease	0.000224	0.00489	CcSEcCtD
Nelarabine—Urinary tract disorder—Mesalazine—Crohn's disease	0.000224	0.00488	CcSEcCtD
Nelarabine—Oedema peripheral—Mesalazine—Crohn's disease	0.000223	0.00487	CcSEcCtD
Nelarabine—Chills—Azathioprine—Crohn's disease	0.000223	0.00487	CcSEcCtD
Nelarabine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000223	0.00486	CcSEcCtD
Nelarabine—Urethral disorder—Mesalazine—Crohn's disease	0.000222	0.00485	CcSEcCtD
Nelarabine—Eye disorder—Mesalazine—Crohn's disease	0.000212	0.00462	CcSEcCtD
Nelarabine—Cardiac disorder—Mesalazine—Crohn's disease	0.00021	0.00459	CcSEcCtD
Nelarabine—Sepsis—Prednisone—Crohn's disease	0.000207	0.00452	CcSEcCtD
Nelarabine—Angiopathy—Mesalazine—Crohn's disease	0.000206	0.00448	CcSEcCtD
Nelarabine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000204	0.00446	CcSEcCtD
Nelarabine—Chills—Mesalazine—Crohn's disease	0.000203	0.00444	CcSEcCtD
Nelarabine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000203	0.00443	CcSEcCtD
Nelarabine—Anaemia—Azathioprine—Crohn's disease	0.0002	0.00437	CcSEcCtD
Nelarabine—Mental disorder—Mesalazine—Crohn's disease	0.000199	0.00433	CcSEcCtD
Nelarabine—Leukopenia—Azathioprine—Crohn's disease	0.000194	0.00423	CcSEcCtD
Nelarabine—Dysgeusia—Mesalazine—Crohn's disease	0.000193	0.00421	CcSEcCtD
Nelarabine—Back pain—Mesalazine—Crohn's disease	0.000191	0.00416	CcSEcCtD
Nelarabine—Vomiting—Mercaptopurine—Crohn's disease	0.000189	0.00411	CcSEcCtD
Nelarabine—Vision blurred—Mesalazine—Crohn's disease	0.000186	0.00406	CcSEcCtD
Nelarabine—Tremor—Mesalazine—Crohn's disease	0.000185	0.00403	CcSEcCtD
Nelarabine—Amnesia—Prednisone—Crohn's disease	0.000184	0.00402	CcSEcCtD
Nelarabine—Myalgia—Azathioprine—Crohn's disease	0.000184	0.00402	CcSEcCtD
Nelarabine—Arthralgia—Azathioprine—Crohn's disease	0.000184	0.00402	CcSEcCtD
Nelarabine—Anaemia—Mesalazine—Crohn's disease	0.000182	0.00398	CcSEcCtD
Nelarabine—Lethargy—Prednisone—Crohn's disease	0.000177	0.00386	CcSEcCtD
Nelarabine—Leukopenia—Mesalazine—Crohn's disease	0.000177	0.00385	CcSEcCtD
Nelarabine—Nausea—Mercaptopurine—Crohn's disease	0.000176	0.00384	CcSEcCtD
Nelarabine—Infection—Azathioprine—Crohn's disease	0.000176	0.00383	CcSEcCtD
Nelarabine—Loss of consciousness—Mesalazine—Crohn's disease	0.000173	0.00378	CcSEcCtD
Nelarabine—Osteoarthritis—Prednisone—Crohn's disease	0.000173	0.00378	CcSEcCtD
Nelarabine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000173	0.00378	CcSEcCtD
Nelarabine—Cough—Mesalazine—Crohn's disease	0.000172	0.00376	CcSEcCtD
Nelarabine—Arthralgia—Mesalazine—Crohn's disease	0.000168	0.00366	CcSEcCtD
Nelarabine—Myalgia—Mesalazine—Crohn's disease	0.000168	0.00366	CcSEcCtD
Nelarabine—Chest pain—Mesalazine—Crohn's disease	0.000168	0.00366	CcSEcCtD
Nelarabine—Hypotension—Azathioprine—Crohn's disease	0.000165	0.0036	CcSEcCtD
Nelarabine—Confusional state—Mesalazine—Crohn's disease	0.000162	0.00354	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000161	0.00351	CcSEcCtD
Nelarabine—Oedema—Mesalazine—Crohn's disease	0.000161	0.00351	CcSEcCtD
Nelarabine—Infection—Mesalazine—Crohn's disease	0.00016	0.00349	CcSEcCtD
Nelarabine—Nervous system disorder—Mesalazine—Crohn's disease	0.000158	0.00344	CcSEcCtD
Nelarabine—Hypokalaemia—Prednisone—Crohn's disease	0.000158	0.00344	CcSEcCtD
Nelarabine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000158	0.00344	CcSEcCtD
Nelarabine—Anorexia—Mesalazine—Crohn's disease	0.000153	0.00335	CcSEcCtD
Nelarabine—Muscular weakness—Prednisone—Crohn's disease	0.000153	0.00333	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000153	0.00333	CcSEcCtD
Nelarabine—Abdominal distension—Prednisone—Crohn's disease	0.000151	0.00329	CcSEcCtD
Nelarabine—Hypotension—Mesalazine—Crohn's disease	0.00015	0.00328	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000147	0.0032	CcSEcCtD
Nelarabine—Feeling abnormal—Azathioprine—Crohn's disease	0.000146	0.00318	CcSEcCtD
Nelarabine—Insomnia—Mesalazine—Crohn's disease	0.000146	0.00318	CcSEcCtD
Nelarabine—Paraesthesia—Mesalazine—Crohn's disease	0.000145	0.00315	CcSEcCtD
Nelarabine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000145	0.00315	CcSEcCtD
Nelarabine—Dyspnoea—Mesalazine—Crohn's disease	0.000144	0.00313	CcSEcCtD
Nelarabine—Somnolence—Mesalazine—Crohn's disease	0.000143	0.00312	CcSEcCtD
Nelarabine—Neutropenia—Prednisone—Crohn's disease	0.00014	0.00306	CcSEcCtD
Nelarabine—Decreased appetite—Mesalazine—Crohn's disease	0.00014	0.00305	CcSEcCtD
Nelarabine—Body temperature increased—Azathioprine—Crohn's disease	0.00014	0.00305	CcSEcCtD
Nelarabine—Abdominal pain—Azathioprine—Crohn's disease	0.00014	0.00305	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000139	0.00303	CcSEcCtD
Nelarabine—Fatigue—Mesalazine—Crohn's disease	0.000139	0.00303	CcSEcCtD
Nelarabine—Pain—Mesalazine—Crohn's disease	0.000138	0.003	CcSEcCtD
Nelarabine—Constipation—Mesalazine—Crohn's disease	0.000138	0.003	CcSEcCtD
Nelarabine—Hyperglycaemia—Prednisone—Crohn's disease	0.000135	0.00295	CcSEcCtD
Nelarabine—Depression—Prednisone—Crohn's disease	0.000133	0.00291	CcSEcCtD
Nelarabine—Feeling abnormal—Mesalazine—Crohn's disease	0.000133	0.00289	CcSEcCtD
Nelarabine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000132	0.00287	CcSEcCtD
Nelarabine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000131	0.00286	CcSEcCtD
Nelarabine—Abdominal pain—Mesalazine—Crohn's disease	0.000127	0.00278	CcSEcCtD
Nelarabine—Body temperature increased—Mesalazine—Crohn's disease	0.000127	0.00278	CcSEcCtD
Nelarabine—Diarrhoea—Azathioprine—Crohn's disease	0.000121	0.00264	CcSEcCtD
Nelarabine—Connective tissue disorder—Prednisone—Crohn's disease	0.000118	0.00257	CcSEcCtD
Nelarabine—Dizziness—Azathioprine—Crohn's disease	0.000117	0.00255	CcSEcCtD
Nelarabine—Asthenia—Mesalazine—Crohn's disease	0.000116	0.00252	CcSEcCtD
Nelarabine—Vomiting—Azathioprine—Crohn's disease	0.000112	0.00245	CcSEcCtD
Nelarabine—Eye disorder—Prednisone—Crohn's disease	0.000112	0.00244	CcSEcCtD
Nelarabine—Headache—Azathioprine—Crohn's disease	0.000111	0.00242	CcSEcCtD
Nelarabine—Diarrhoea—Mesalazine—Crohn's disease	0.00011	0.0024	CcSEcCtD
Nelarabine—Angiopathy—Prednisone—Crohn's disease	0.000109	0.00237	CcSEcCtD
Nelarabine—Dizziness—Mesalazine—Crohn's disease	0.000106	0.00232	CcSEcCtD
Nelarabine—Mental disorder—Prednisone—Crohn's disease	0.000105	0.00229	CcSEcCtD
Nelarabine—Nausea—Azathioprine—Crohn's disease	0.000105	0.00229	CcSEcCtD
Nelarabine—Malnutrition—Prednisone—Crohn's disease	0.000104	0.00228	CcSEcCtD
Nelarabine—Vomiting—Mesalazine—Crohn's disease	0.000102	0.00223	CcSEcCtD
Nelarabine—Headache—Mesalazine—Crohn's disease	0.000101	0.0022	CcSEcCtD
Nelarabine—Vision blurred—Prednisone—Crohn's disease	9.84e-05	0.00215	CcSEcCtD
Nelarabine—Anaemia—Prednisone—Crohn's disease	9.65e-05	0.0021	CcSEcCtD
Nelarabine—Nausea—Mesalazine—Crohn's disease	9.56e-05	0.00209	CcSEcCtD
Nelarabine—Loss of consciousness—Prednisone—Crohn's disease	9.17e-05	0.002	CcSEcCtD
Nelarabine—Convulsion—Prednisone—Crohn's disease	9.04e-05	0.00197	CcSEcCtD
Nelarabine—Myalgia—Prednisone—Crohn's disease	8.89e-05	0.00194	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—Crohn's disease	8.89e-05	0.00194	CcSEcCtD
Nelarabine—Oedema—Prednisone—Crohn's disease	8.52e-05	0.00186	CcSEcCtD
Nelarabine—Infection—Prednisone—Crohn's disease	8.46e-05	0.00185	CcSEcCtD
Nelarabine—Nervous system disorder—Prednisone—Crohn's disease	8.35e-05	0.00182	CcSEcCtD
Nelarabine—Anorexia—Prednisone—Crohn's disease	8.12e-05	0.00177	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Prednisone—Crohn's disease	7.76e-05	0.00169	CcSEcCtD
Nelarabine—Insomnia—Prednisone—Crohn's disease	7.7e-05	0.00168	CcSEcCtD
Nelarabine—Paraesthesia—Prednisone—Crohn's disease	7.65e-05	0.00167	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—Crohn's disease	7.41e-05	0.00162	CcSEcCtD
Nelarabine—Fatigue—Prednisone—Crohn's disease	7.34e-05	0.0016	CcSEcCtD
Nelarabine—Constipation—Prednisone—Crohn's disease	7.28e-05	0.00159	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisone—Crohn's disease	7.02e-05	0.00153	CcSEcCtD
Nelarabine—Gastrointestinal pain—Prednisone—Crohn's disease	6.97e-05	0.00152	CcSEcCtD
Nelarabine—Body temperature increased—Prednisone—Crohn's disease	6.73e-05	0.00147	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—Crohn's disease	6.73e-05	0.00147	CcSEcCtD
Nelarabine—Asthenia—Prednisone—Crohn's disease	6.11e-05	0.00133	CcSEcCtD
Nelarabine—Diarrhoea—Prednisone—Crohn's disease	5.83e-05	0.00127	CcSEcCtD
Nelarabine—Dizziness—Prednisone—Crohn's disease	5.63e-05	0.00123	CcSEcCtD
Nelarabine—Vomiting—Prednisone—Crohn's disease	5.42e-05	0.00118	CcSEcCtD
Nelarabine—Headache—Prednisone—Crohn's disease	5.34e-05	0.00116	CcSEcCtD
Nelarabine—Nausea—Prednisone—Crohn's disease	5.06e-05	0.0011	CcSEcCtD
